| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
14,163 |
9,478 |
$1.89M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,360 |
965 |
$30K |
| 87428 |
|
604 |
408 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
281 |
255 |
$10K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
270 |
155 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
811 |
697 |
$304.13 |
| 90686 |
|
24 |
16 |
$242.10 |
| 80305 |
|
2,412 |
1,844 |
$214.69 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
530 |
412 |
$178.18 |
| 36415 |
Collection of venous blood by venipuncture |
1,091 |
990 |
$177.00 |
| Q3014 |
Telehealth originating site facility fee |
15 |
12 |
$25.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
168 |
160 |
$22.36 |
| 81003 |
|
72 |
57 |
$7.43 |
| 82044 |
|
56 |
54 |
$5.91 |
| 81002 |
|
36 |
30 |
$0.49 |
| 1000F |
|
482 |
426 |
$0.07 |
| 3079F |
|
227 |
208 |
$0.01 |
| 1159F |
|
498 |
429 |
$0.01 |
| 3074F |
|
520 |
470 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
322 |
263 |
$0.00 |
| 4000F |
|
14 |
12 |
$0.00 |
| 1034F |
|
161 |
148 |
$0.00 |
| 3080F |
|
51 |
48 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
107 |
96 |
$0.00 |
| 1220F |
|
76 |
68 |
$0.00 |
| 3075F |
|
76 |
71 |
$0.00 |
| 1036F |
|
66 |
63 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
84 |
69 |
$0.00 |
| 99441 |
|
29 |
27 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$0.00 |
| 1160F |
|
81 |
77 |
$0.00 |
| 3078F |
|
379 |
341 |
$0.00 |
| 3077F |
|
111 |
107 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
56 |
54 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
53 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
46 |
41 |
$0.00 |